Future challenges in quality improvement in heart failure

Congestive Heart Failure

Volumn 8, Issue 6, 2002, Pages 342-345

  Havranek, Edward P ^a,b,c   Masoudi, Frederick A ^a,b,c   Ralston, Debra L ^c   Susman, Nancy J ^c   Krumholz, Harlan M ^c,d   Taylor, Jane P ^e  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Colorado Foundation for Medical Care ^*  (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Centers for Medicare and Medicaid Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; COMORBIDITY; HEALTH CARE QUALITY; HEALTH PROGRAM; HEART FAILURE; HUMAN; MEDICAID; MEDICARE; PATIENT CARE; PRACTICE GUIDELINE; SAFETY;

EID: 0036857432     PISSN: 10797998     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-5299.2002.01454.x     Document Type: Article

References (13)

1. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
2. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685-691.
3. Hunt HA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 guidelines for the evaluation and management of heart failure): Developed in collaboration with the International Society for Heart and Lung Transplantation; endorsed by the Heart Failure Society of America. Circulation. 2001;104:2996-3007.
4. Jencks SF, Cuerdon T, Burwen DR, et al. Quality of medical care delivered to Medicare beneficiaries: A profile at state and national levels. JAMA. 2000;284:1670-1676.
5. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709-717.
6. Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med. 2002;162:1682-1688.
7. Miller T, Leatherman S. The National Quality Forum: A 'metoo' or a breakthrough in quality measurement and reporting? Health Affairs. 1999;18:233-237.
8. Berwick DM. Public performance reports and the will for change. JAMA. 2002;288:1523-1524.
9. Daley J, Jencks S, Draper D. Predicting hospital-associated mortality for Medicare patients. A method for patients with stroke, pneumonia, acute myocardial infarction, and congestive heart failure. JAMA. 1988;260:3617-3624.
10. Marshall MN, Shekelle PG, Leatherman S, et al. The public release of performance data: What do we expect to gain? A review of the evidence. JAMA. 2000;283:1866-1874.
11. Scully T. Keynote address. Eighth Annual Picker Symposium. July 2002. Available at: http://www.patientexperiencestandard.org/events/eventsmore.asp. Accessed October 16, 2002.
12. Havranek EP, Masoudi FA, Westfall KA, et al. Spectrum of heart failure in older patients: Results from the National Heart Failure project. Am Heart J. 2002;143:412-417.
13. Jencks SF, Daley J, Draper D, et al. Interpreting hospital mortality data. The role of clinical risk adjustment. JAMA. 1988;260:3611-3616.